Global PICC Devices Market to Surge at 7.89% CAGR During 2026-30 Due to Rising Incidences of Chronic Diseases

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

Global Peripherally Inserted Central Catheter (PICC) Devices Market Overview, Trends, Size and Forecast: 2026-2030

The Global Peripherally Inserted Central Catheter (PICC) Devices Market size was valued at around USD1,022 million in 2024 and is projected to reach USD1,612 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.89% during the forecast period, i.e., 2026-30, cites MarkNtel Advisors in the recent research report.

Growing cases associated with renal failure, various types of cancer, and tuberculosis are driving the demand in the market. For patients with TB and cancer, long-term treatments are usually done lasting for weeks up to a year. These treatments require the administration of drugs, infusion of nutrients, and frequent need for blood extraction, and to avoid regular needle puncture and increase patient comfort, PICC devices are required by hospitals, which propels their market growth worldwide. For instance, the WHO stated 20 million new cases of cancer globally in the year 2024, and these are projected to surge to 32.6 million by 2045. Tuberculosis (TB) is yet another infectious disease. Its treatment may last from several weeks up to a year, and patients suffering from this require administration of nutrients and medications for a long period and thus driving demand for PICC devices.

Moreover, the countries in the Asia region are expected to spend more than USD500 billion per year on healthcare services. Majorly, the investments will be directed towards the creation of additional capacities such as hospitals, specialty centers, etc. Moreover, the focus is expected to be higher on the integration of advanced devices and procedures into the mainstream healthcare industry.

Further, growth in product innovations is also propelling market demand for these devices in hospitals globally. For instance, Arrow PICC, an advanced device, is developed with antimicrobial and Antithrombogenic layers of protection. Chlorhexidine is coated on their internal and external surfaces, which reduces blood clot formation, irritation, and catheter-related infection on the body. In 2023, NaviCurve Stylet and Arrow VPS Rhythm DLX are two advanced PICC devices introduced by Teleflex Incorporated. These assist in the easy insertion of PICC devices and have reduced the complication rate, further states the research report, “Global Peripherally Inserted Central Catheter (PICC) Devices Market, 2026.”

Global Peripherally Inserted Central Catheter (PICC) Devices Market Segmentation Insights:

Triple Lumen is the Most Preferred Design

Based on the design, the market is segmented into Single Lumen, Double Lumen, and Triple Lumen. Among these, the Triple Lumen category holds the largest market share, about 53% and is expected to hold its position during the forecast period as well. The growth is driven by the extensive usage of PICC devices in intensive care units (ICUs), where patients require frequent medication or drug infusion at once. In addition, triple lumens offer three separate channels, which help the doctors to give two to three drugs at the same time, without the requirement of another needle insertion into the veins. These factors have cemented the leading position of the triple-lumen segment in the PICC devices industry.

Global Peripherally Inserted Central Catheter (PICC) Devices Market Regional Analysis:

North America Leads the Global Peripherally Inserted Central Catheter (PICC) Devices Industry

North America is leading the Global Peripherally Inserted Central Catheter (PICC) Devices Industry with a market share of around 47.25%. The dominance of the region is based on the rising cases of Kidney failure and cancer, and increasing government support for the healthcare sector in the region. PICC devices are a major component in chemotherapy as they provide long-term venous access to facilitate chemotherapy, reduce pain with frequent needle pricks, and allow easy blood draws from the veins. Cancer patients are increasing at a faster rate in North America.

As per the Global Cancer Observatory, the number of cancers in North America was 2.67 million in 2024, and is expected to rise to 3.83 million by 2045. Thus, the demand for PICC devices is projected to increase in the region during the forecast period. The government’s investment in healthcare in North America is yet another factor supporting the dominance of this region. In 2023, USD4.9 trillion was spent by the United States on healthcare. Further, the rise in the number of cases of kidney failure is also impacting PICC devices in the U.S. For instance, as per the American Kidney Fund, in 2025, almost 0.86 million Americans are living with kidney failure, and almost 555,000 Americans are on dialysis. Thus, Kidney failure patients with comorbid conditions like diabetes, vascular disease, and heart failure often require intravenous therapies, like antibiotics to treat infections, for which PICC devices are used to insert medicines into the patient's body. These factors are making North America the leading region in the global PICC devices industry.

Top Companies in the Global Peripherally Inserted Central Catheter (PICC) Devices Market

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading Peripherally Inserted Central Catheter (PICC) Devices Market companies, including B. Braun Melsungen AG, Cardinal Health, BD, Teleflex Incorporated, Argon Medical Devices, Cook Group, ICU Medical Inc., Medical Components Inc., Access Vascular Inc., Vygon SAS, Meditech Devices, Biowy Corporation, Polymedicure, Footprint Medical Inc., INSUNG MEDICAL Co., Ltd., and others are looking forward to increase their market size & share.

Key Questions Answered in the Research Report

1. What is the scope, size, value, and forecast of the Peripherally Inserted Central Catheter (PICC) Devices Market?
2. What is the volume and share of each segment in the Peripherally Inserted Central Catheter (PICC) Devices Market?
3. What are the key trends shaping the Peripherally Inserted Central Catheter (PICC) Devices Market from 2026 to 2030?
4. What growth factors and risks impact the Peripherally Inserted Central Catheter (PICC) Devices Market?
5. What are the main challenges faced by players in the Peripherally Inserted Central Catheter (PICC) Devices Market?
6. What are the top opportunities in the Peripherally Inserted Central Catheter (PICC) Devices Market?
7. What does competitive analysis reveal about the Peripherally Inserted Central Catheter (PICC) Devices Market landscape?
8. Who are the key players and companies leading the Peripherally Inserted Central Catheter (PICC) Devices Market?
9. What innovations are transforming the future dynamics of the Peripherally Inserted Central Catheter (PICC) Devices Market?
10. How are partnerships and collaborations driving the Peripherally Inserted Central Catheter (PICC) Devices Market growth?
11. How does the Peripherally Inserted Central Catheter (PICC) Devices Market differ based on geography and segments?